Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human WEE1 Stable Cell Line

    [CAT#: S01YF-1023-PY129]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX524 Magic™ Human WEE1 in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;NCI-H322
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cancer Research
    Related Diseases
    Ciliary Dyskinesia, Primary, 20; Vulva Cancer
    Gene ID
    Human:7465
    UniProt ID
    Human:P30291

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    WEE1 is a protein kinase that has applications in various cancer treatments. In lung adenocarcinoma, WEE1 inhibition, in combination with E2F8 knockdown, has been shown to suppress cancer cell proliferation and promote apoptosis. In bladder cancer, a nanoparticle loaded with a WEE1 inhibitor and a platinum prodrug has been designed to stimulate the STING pathway, modify the immunosuppressive microenvironment, and increase the response rate to immune checkpoint blockers. In ovarian cancer, targeting WEE1 has shown promising signs of activity in increasing the sensitivity of homologous recombination proficiency tumors to poly (ADP-ribose) polymerase inhibitors. In clear cell ovarian cancer, combining a BRD4 inhibitor with ATR or WEE1 inhibitors has been found to be synergistic and effective in treating ARID1A-deficient tumors. In T lymphoblastic leukemia, bortezomib, a proteasome inhibitor, has been shown to induce DNA damage, downregulate WEE1, and cause mitotic catastrophe, suggesting its potential as a treatment for T-ALL.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human WEE1 Stable Cell Line (S01YF-1023-PY129). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Alex Garcia (Verified Customer)

    What is the role of WEE1 in the DNA damage response? Jun 08 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    WEE1 kinase is a crucial regulator in the DNA damage response, and its inhibition, combined with genotoxic agents, offers a therapeutic strategy in cancer treatment. Jun 08 2023

    chat Alex Davis (Verified Customer)

    How does WEE1 contribute to the stability of stalled DNA replication forks? Jul 20 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    WEE1 kinase protects the stability of stalled DNA replication forks by limiting CDK2 activity, which is crucial for safeguarding DNA replication initiation. Jul 20 2023
    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare